[Clinico-cytological features of local treatment for slow-granulating soft tissue wounds with 0,2% curiosine solution in phase II of healing process (data from registration studies)].
Gostishchev
V K
VK
Khanin
A G
AG
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012042:Registries; D031955:Rhamnus / Q000627:therapeutic use; D017695:Soft Tissue Injuries / Q000188:drug therapy / Q000473:pathology*; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects*; D014946:Wound Infection / Q000188:drug therapy / Q000473:pathology*; D015032:Zinc / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D009824:Ointments; D006820:Hyaluronic Acid; D015032:Zinc